• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】45439

【品名】dimethylformamide

【CA登记号】

【 分 子 式 】C3H7NO

【 分 子 量 】73.09472

【元素组成】C 49.3% H 9.65% N 19.16% O 21.89%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(V)

The protection of 4-bromo-2-methoxyphenol (I) with ethyl vinyl ether (II) and TsOH in dichloromethane gives the ethoxyethyl ether (III), which is treated with n-BuLi in THF to yield the phenyl lithium compound (IV). The reaction of (IV) with 2H-labeled DMF (V), followed by hydrolysis with HCl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (VI), which is finally condensed with pentane-2,4-dione (VII) by means of B2O3 and tetrahydroquinoline in DMF.

1 Threadgill, M.D.; Parveen, I.; Labelled compounds of interest as antitumour agents - VII. [H-2]- and [C-14]-curcumin. J Label Compd Radiopharm 2000, 43, 9, 883.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45436 4-bromo-2-methoxyphenol 7368-78-7 C7H7BrO2 详情 详情
(II) 18762 1-Ethoxyethylene; Ethyl vinyl ether;Ethoxyethene 109-92-2 C4H8O 详情 详情
(III) 45437 5-bromo-2-(1-ethoxyethoxy)phenyl methyl ether; 4-bromo-1-(1-ethoxyethoxy)-2-methoxybenzene C11H15BrO3 详情 详情
(IV) 45438 [4-(1-ethoxyethoxy)-3-methoxyphenyl]lithium C11H15LiO3 详情 详情
(V) 33491 Dimethylformamide 68-12-2 C3H7NO 详情 详情
(V) 45439 dimethylformamide C3H7NO 详情 详情
(VI) 22701 4-hydroxy-3-methoxybenzaldehyde 121-33-5 C8H8O3 详情 详情
(VI) 45440 4-hydroxy-3-methoxybenzaldehyde 21-59-0 C8H8O3 详情 详情
(VII) 11620 2,4-Pentanedione;acetylacetone 123-54-6 C5H8O2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The reaction of 2,3-dihydrobenzofuran (I) with DMF (II) and POCl3 gives 2,3-dihydrobenzofuran-5-carbaldehyde (III), which is condensed with the phosphonate (IV) by means of t-BuONa in toluene to yield the acrylate (V). The reduction of (V) with H2 over Pd/C in AcOH affords the corresponding propionate (VI), which is brominated with Br2 in AcOH to provide the dibromo derivative (VII). The hydrolysis of the ester group of (VII) in acidic medium gives the expected propionic acid derivative (VIII), which is treated with SOCl2 in dichloromethane to yield the propionyl chloride (IX). The cyclization of (IX) by means of AlCl3 in dichloromethane affords the 4,5-dibromo-2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-one (X), which is submitted to an hydrogenolytic debromination with H2 over Pd/C in methanol to provide the 2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-one (XI). The Wittig condensation of (XI) with phosphonate (XII) by means of NaOMe in toluene gives 2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-ylidene)acetonitrile (XIII), which is reduced with H2 and Raney-Co in toluene/MeOH to yield 2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8-ylidene)ethylamine (XIV). The asymmetric reduction of (XIV) with H2 and a chiral Ru catalyst in toluene/MeOH affords the 2-(2,6,7,8-tetrahydro-1H-indeno[5,4-b]furan-8(S)-yl)ethylamine (XV), which is finally acylated with propionyl chloride (XVI) and NaOH in aq. THF to provide the target chiral propionamide.

1 Ohkawa, S.; Discovery of the novel melatonin agonist TAK-375. 22nd Symp Med Chem (Nov 27 2002, Shizuoka) 2002, Abst IL 11.
2 Chilman-Blair, K.; Castaner, J.; Silvestre, J.S.; Bayes, M.; TAK-375. Drugs Fut 2003, 28, 10, 950.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14499 2,3-Dihydrobenzofuran; 2,3-dihydro-1-benzofuran 496-16-2 C8H8O 详情 详情
(II) 45439 dimethylformamide C3H7NO 详情 详情
(III) 52198 2,3-Dihydrobenzo[b]furan-5-carboxaldehyde C9H8O2 详情 详情
(IV) 10019 Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate 867-13-0 C8H17O5P 详情 详情
(V) 57393 ethyl (E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-propenoate C13H14O3 详情 详情
(VI) 57394 ethyl 3-(2,3-dihydro-1-benzofuran-5-yl)propanoate C13H16O3 详情 详情
(VII) 57396 ethyl 3-(6,7-dibromo-2,3-dihydro-1-benzofuran-5-yl)propanoate C13H14Br2O3 详情 详情
(VIII) 57397 3-(6,7-dibromo-2,3-dihydro-1-benzofuran-5-yl)propanoic acid C11H10Br2O3 详情 详情
(IX) 57398 3-(6,7-dibromo-2,3-dihydro-1-benzofuran-5-yl)propanoyl chloride C11H9Br2ClO2 详情 详情
(X) 57399 4,5-dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one C11H8Br2O2 详情 详情
(XI) 57400 1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one C11H10O2 详情 详情
(XII) 10045 Diethyl cyanomethylphosphonate 2537-48-6 C6H12NO3P 详情 详情
(XIII) 57401 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile C13H11NO 详情 详情
(XIV) 57402 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)-1-ethanamine; 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethylamine C13H15NO 详情 详情
(XV) 62217 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]-1-ethanamine; 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethylamine C13H17NO 详情 详情
(XVI) 15967 propanoyl chloride; propionyl chloride 79-03-8 C3H5ClO 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

 

1 Urayruna S. Mutou E, Inagaki A, et aL. 2006. Preparation of (S)-2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-yl) ethylamine derivative by asymmetric hydrogenation of 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b] furan-8-ylidene) ethylamine. W0 2006030739(本专利属于Takeda Pharmaceutical company Limited, Japan)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 45439 dimethylformamide C3H7NO 详情 详情
(II) 14499 2,3-Dihydrobenzofuran; 2,3-dihydro-1-benzofuran 496-16-2 C8H8O 详情 详情
(III) 52198 2,3-Dihydrobenzo[b]furan-5-carboxaldehyde C9H8O2 详情 详情
(IV) 57393 ethyl (E)-3-(2,3-dihydro-1-benzofuran-5-yl)-2-propenoate C13H14O3 详情 详情
(V) 57394 ethyl 3-(2,3-dihydro-1-benzofuran-5-yl)propanoate C13H16O3 详情 详情
(VI) 57396 ethyl 3-(6,7-dibromo-2,3-dihydro-1-benzofuran-5-yl)propanoate C13H14Br2O3 详情 详情
(VII) 57399 4,5-dibromo-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one C11H8Br2O2 详情 详情
(VIII) 57400 1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-one C11H10O2 详情 详情
(IX) 57401 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile C13H11NO 详情 详情
(X) 57402 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)-1-ethanamine; 2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethylamine C13H15NO 详情 详情
(XI) 62217 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]-1-ethanamine; 2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethylamine C13H17NO 详情 详情
Extended Information